1 min read
Meeting the Broader Health Needs of People Who Use Drugs
Meeting the broader health needs of people who use drugs means delivering primary care alongside substance use services, because the same people who...
6 min read
Mollie Williams, DrPH, MPH
July 3, 2026
Mobile HIV and STI testing brings rapid, confidential screening for HIV, hepatitis, and sexually transmitted infections directly to the places where people already are, rather than waiting for them to visit a clinic. A testing unit parks at neighborhood events, shelters, syringe services sites, jails on release, and community partners, offers same-visit rapid results, and connects anyone who tests positive to treatment on the spot. The model exists because a large share of infection spreads from people who do not know their status, and many of those people will not walk into a fixed clinic. Meeting them where they are turns a test they would have skipped into a diagnosis, a treatment plan, and a chance to prevent onward transmission.
The stakes are concrete. About 1.2 million people in the US have HIV, roughly 158,500 do not know it, and nearly 40% of new HIV infections come from people unaware they have the virus, per a review in PMC. Testing is the first step in stopping that chain, and a mobile program reaches the people a fixed site rarely sees.
Mobile HIV and STI testing is a community-based service that delivers screening for HIV, hepatitis, and other sexually transmitted infections from a vehicle or portable setup on a scheduled route. Staff offer rapid tests with results in minutes, counsel people on what the results mean, and link anyone who needs care to treatment and prevention. The service is designed to be low-barrier: no appointment, no insurance requirement to get tested, and a location chosen for how easy it is to reach rather than how convenient it is for the provider.
Mobile clinics already deliver preventive, diagnostic, maternal, chronic disease, dental, and behavioral care in communities without a fixed site, as Georgetown's review of mobile health in state rural health transformation plans describes. Infectious disease testing fits the model because it is fast, high-volume, and most effective when it goes to the people least likely to seek it out. The unit becomes a familiar, trusted presence, which is what gets people to test again and to come back for results and follow-up.
A mobile unit can screen for a broad panel of infections and, increasingly, start treatment and prevention in the same visit. Testing typically covers:
Hepatitis C screening matters because risk climbs steeply with time. Among people who inject drugs, hepatitis C prevalence runs about 30% at three years of injecting and up to about 60% at eight or more years, per a study in Frontiers in Public Health. That trajectory is why reaching people early, at the sites where they already gather, changes outcomes. A unit that tests, counsels, and connects to treatment in one stop shortens the distance between infection and care.
Outreach testing reaches people fixed sites miss because it removes the travel, cost, and trust barriers that keep those people from ever showing up. The people most at risk are often the least connected to traditional care, and asking them to find a clinic, get there, and wait is asking too much. A mobile unit inverts the model: it goes to the corner, the shelter, the syringe services site, and offers a test with no appointment and results before the person leaves.
The barrier this addresses is measurable. Transportation problems cause delayed or foregone care for up to 3.6 million people a year and account for a quarter or more of missed appointments, per a review in PMC. For infectious disease, a missed appointment is not just a personal setback; an undiagnosed infection can spread. That is why closing the gap matters so much: nearly 40% of new HIV infections come from people who do not know their status, per PMC. Bringing the test to the person is how a program finds the infections a waiting room never will.
Testing only matters if it leads to care, so a strong mobile program builds the bridge from result to treatment before the first test is run. A positive result on the unit should trigger a defined path: counseling, same-visit or rapid linkage to HIV or hepatitis C treatment, and follow-up to confirm the person actually started. A negative result is an opening too, especially for people at ongoing risk, who can be offered PrEP for HIV prevention and connected to a prescriber.
Speed and follow-through are what make the connection real. With roughly 158,500 people unaware they have HIV, per PMC, the diagnosis is the moment care becomes possible, and losing the person between the test and the treatment wastes it. Mobile programs handle this with warm handoffs, navigation support, and telehealth where a prescriber can start treatment or PrEP without a separate trip. Coordinating those handoffs across recurring sites is easier when the testing program is part of a connected satellite clinic network rather than a series of one-off events.
Mobile testing integrates naturally with substance use and harm reduction services because they reach the same people at the same sites. Syringe services programs are one of the strongest access points: they bridge people to HIV and hepatitis C testing and treatment and to medication for opioid use disorder, per the CDC. Co-locating or coordinating testing with these programs means a person can get tested, get supplies, and get connected to treatment in a single trusted interaction.
The clinical case is clear from the numbers. Hepatitis C prevalence among people who inject drugs rises from about 30% at three years to about 60% at eight or more years, per Frontiers in Public Health, so the population served by harm reduction is precisely the population that needs regular testing and fast treatment. Integrating with substance use care also opens the door to behavioral health, since the same visit can connect someone to counseling and recovery services. A behavioral health satellite clinic network gives testing programs a place to route people for the mental health and substance use care that so often accompanies infectious disease risk.
You plan a mobile testing program the same way you plan any durable mobile service: around the people you are trying to reach, with dedicated staff, reliable sites, and a treatment pathway built before you launch.
Trust is the currency of this work, and trust comes from showing up, in the same place, with the same faces, on schedule. The operational load behind that consistency, from route design and site agreements to compliance and staffing, is where programs most often stumble, and it is worth planning through mobile health operations support rather than improvising. Get the route, the staffing, and the treatment pathway right, and the testing takes care of itself.
Rapid HIV tests used on mobile units provide reliable preliminary results in minutes, and any reactive result is confirmed with follow-up testing before a diagnosis is final. The value of same-visit results is that people learn their status before they leave, which matters because nearly 40% of new HIV infections come from people who do not know they have the virus, per PMC.
Many programs are designed for exactly this. A positive result can trigger rapid linkage to treatment, and a person at ongoing risk can be offered PrEP for prevention, often with telehealth support from a prescriber. Building that pathway before launch is what keeps people from being lost between the test and the care.
Syringe services programs reach people at high risk and already bridge them to HIV and hepatitis C testing and treatment and to medication for opioid use disorder, per the CDC. Hepatitis C prevalence among people who inject drugs rises with years injecting, so these sites reach the population that most needs regular testing.
No. Mobile testing programs are built to be low-barrier, and testing is generally offered regardless of insurance status. Removing that requirement is part of reaching people who would otherwise skip care, given that transportation and access barriers already cause delayed or foregone care for up to 3.6 million people a year, per PMC.
Units are designed with private space for testing and counseling, and staff follow the same confidentiality standards as a fixed clinic. Confidentiality is central to trust, and trust is what brings people back for repeat testing and follow-up care.
Ready to reach the people who miss care? Learn how a behavioral health satellite clinic network can connect your testing program to the substance use and mental health care that so often goes with it.
1 min read
Meeting the broader health needs of people who use drugs means delivering primary care alongside substance use services, because the same people who...
1 min read
Treating HIV and hepatitis C among people who use drugs works best when testing, treatment, and medications for opioid use disorder (MOUD) sit in the...
1 min read
Harm reduction is a set of practical strategies that reduce the health risks of drug use for people who are still using, without requiring them to...